118 related articles for article (PubMed ID: 23061738)
1. Urinary mRNA expression of CCN2/CCN3 as a noninvasive marker for monitoring glomerular structure changes in nondiabetic chronic kidney disease.
Chen L; Wu YG; Liu D; Lv LL; Zheng M; Ni HF; Cao YH; Liu H; Zhang P; Zhang JD; Liu BC
Biomarkers; 2012 Dec; 17(8):714-20. PubMed ID: 23061738
[TBL] [Abstract][Full Text] [Related]
2. Roles of heterotypic CCN2/CTGF-CCN3/NOV and homotypic CCN2-CCN2 interactions in expression of the differentiated phenotype of chondrocytes.
Hoshijima M; Hattori T; Aoyama E; Nishida T; Yamashiro T; Takigawa M
FEBS J; 2012 Oct; 279(19):3584-3597. PubMed ID: 22812570
[TBL] [Abstract][Full Text] [Related]
3. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
4. Protein Imaging of CCN2 and CCN3 in Living Cells.
Hattori T; Hoshijima M; Takigawa M
Methods Mol Biol; 2017; 1489():211-215. PubMed ID: 27734379
[TBL] [Abstract][Full Text] [Related]
5. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
Kubota S; Kawata K; Hattori T; Nishida T
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
[TBL] [Abstract][Full Text] [Related]
7. Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases.
Wei Z; Kwan BC; Chow KM; Cheng PM; Luk CC; Lai KB; Li PK; Szeto CC
BMC Nephrol; 2018 Dec; 19(1):367. PubMed ID: 30567508
[TBL] [Abstract][Full Text] [Related]
8. Urinary vimentin mRNA as a potential novel biomarker of renal fibrosis.
Cao YH; Lv LL; Zhang X; Hu H; Ding LH; Yin D; Zhang YZ; Ni HF; Chen PS; Liu BC
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F514-22. PubMed ID: 25904701
[TBL] [Abstract][Full Text] [Related]
9. Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.
Marchal PO; Kavvadas P; Abed A; Kazazian C; Authier F; Koseki H; Hiraoka S; Boffa JJ; Martinerie C; Chadjichristos CE
PLoS One; 2015; 10(9):e0137876. PubMed ID: 26367310
[TBL] [Abstract][Full Text] [Related]
10. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J
Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
12. Myeloid Zinc Finger 1 (MZF-1) Regulates Expression of the CCN2/CTGF and CCN3/NOV Genes in the Hematopoietic Compartment.
Piszczatowski RT; Rafferty BJ; Rozado A; Parziale JV; Lents NH
J Cell Physiol; 2015 Nov; 230(11):2634-9. PubMed ID: 25899830
[TBL] [Abstract][Full Text] [Related]
13. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
Fukuda A; Sato Y; Iwakiri T; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757
[TBL] [Abstract][Full Text] [Related]
14. mRNA expression of target genes in the urinary sediment as a noninvasive prognostic indicator of CKD.
Szeto CC; Chow KM; Lai KB; Szeto CY; Chan RW; Kwan BC; Chung KY; Li PK; Lai FM
Am J Kidney Dis; 2006 Apr; 47(4):578-86. PubMed ID: 16564935
[TBL] [Abstract][Full Text] [Related]
15. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
16. [Urinary biomarkers of kidney dysfunction].
Piéroni L; Cristol JP
Ann Biol Clin (Paris); 2015; 73(2):151-7. PubMed ID: 25847736
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
19. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z
J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065
[TBL] [Abstract][Full Text] [Related]
20. [Urinary biomarkers for chronic kidney disease: a focus on gene transcript].
Lyu LL; Liu BC
Sheng Li Xue Bao; 2018 Dec; 70(6):644-648. PubMed ID: 30560274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
